[go: up one dir, main page]

EP0040346B1 - Process for refining a raw condensation product from aminoalkylalkanol amines and fatty acids, and as soon as required for the subsequent recovery of amphotensides with higher stability - Google Patents

Process for refining a raw condensation product from aminoalkylalkanol amines and fatty acids, and as soon as required for the subsequent recovery of amphotensides with higher stability Download PDF

Info

Publication number
EP0040346B1
EP0040346B1 EP81103328A EP81103328A EP0040346B1 EP 0040346 B1 EP0040346 B1 EP 0040346B1 EP 81103328 A EP81103328 A EP 81103328A EP 81103328 A EP81103328 A EP 81103328A EP 0040346 B1 EP0040346 B1 EP 0040346B1
Authority
EP
European Patent Office
Prior art keywords
condensation product
fatty acids
mol
product
crude
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP81103328A
Other languages
German (de)
French (fr)
Other versions
EP0040346A1 (en
Inventor
Uwe Dr. Ploog
Günter Uphues
Manfred Petzold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to AT81103328T priority Critical patent/ATE5815T1/en
Publication of EP0040346A1 publication Critical patent/EP0040346A1/en
Application granted granted Critical
Publication of EP0040346B1 publication Critical patent/EP0040346B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds

Definitions

  • amphoteric surfactants An important process for the production of amphoteric surfactants is based on condensation products of N-monosubstituted alkylenediamines, which are alkylated in a further reaction with alkylating agents, for example sodium chloroacetate. Products based on N-aminoethylethanolamine and fatty acids play a major role as skin-friendly surfactants.
  • the quality of the ampotensides obtained and in particular their storage stability is crucially determined by the purity of the imidazoline derivative obtained in the first condensation step.
  • the reaction between fatty acids and aminoalkylalkanolamines not only proceeds in the direction of the formation of the desired imidazoline derivative, multiple side reactions complicate the course of the reaction.
  • the importance of this aspect has only recently been emphasized again, see EG Lomax "New and improved balanced amphoterics", Manufacturing Chemist and Aerosol News, Volume 50 No. 8, August 1979, pages 39 and 41.
  • EG Lomax New and improved balanced amphoterics
  • the undesirable side reactions in the stage of imidazoline formation can be suppressed by an excess of aminoethylethanolamine, but this excess must be removed at the end of the reaction by distillation.
  • the invention is based on the object of creating improvements in the production of the class of amphoteric surfactants described here, which are characterized in particular by increased storage stability of the amphoteric surfactants.
  • the invention aims to eliminate the troublesome by-products present here by switching on a simple cleaning step on the condensate of aminoalkylalkanolamine and fatty acid obtained in the first place.
  • the aim of the invention is to make the previously expensive detours for obtaining the purest possible condensation product of this first process stage superfluous.
  • the teaching of the invention is based on the surprising finding that the crude condensation product of fatty acids and aminoalkylalkanolamines can be converted by simple alkaline hydrolysis to a refined product which, in the subsequent alkylation and optionally quaternization, provides improved amphoteric surfactants with, in particular, increased storage stability.
  • the invention accordingly relates to a process for refining the crude condensation product from aminoalkylalkanolamines of the general formula in which n is the number 2 or 3, and fatty acids having 6 to 22 carbon atoms and, if desired, for subsequent alkylation and, if appropriate, quaternization of the purified condensation product to amphoteric surfactants with increased storage stability, this process being characterized in that the crude condensation product is obtained from fatty acids and subjecting aminoalkylalkanolamines to alkaline hydrolysis at 70 to 100 ° C.
  • the amount of alkali used in this alkaline hydrolysis is preferably based on the amount of the diamide of the general amount present in the crude condensate formula Voted.
  • the amount of alkali in particular is such that it is preferably present in the crude condensation product in at least an approximately equimolar amount to the diamide.
  • the invention is based on the finding that the content of disruptive by-products in the finished surfactant can be drastically reduced if the fatty acid / amine condensation product is subjected to an alkaline pretreatment in an aqueous medium before a further reaction with alkylating agents.
  • diamide formed in particular in the course of the reaction by aqueous alkali on the tert.
  • Amide group quantitatively split into the monoamide of the primary amino group and fatty acid.
  • the fatty acid forms soap which can remain in the reaction mixture.
  • the alkaline pretreatment according to the invention gives products which remain clear even after dilution for longer than 6 months. Costly cleaning steps such as recovery of the excess amine or distillation of the imidazoline are no longer necessary.
  • the alkaline hydrolytic treatment according to the invention is preferably carried out in the temperature range from 80 to 90 ° C.
  • Alkali hydroxides, especially sodium hydroxide, are particularly suitable as alkalis.
  • the amount of alkali is preferably in the range of about 1 to 3 times the equimolar amount of alkali, based on the diamide present in the crude condensation product. In particular, alkali amounts in the range of 1 to 2 equivalents, based on diamide, are used.
  • the crude condensation product is expediently suspended in an amount of water which corresponds to 0.5 to 10 times, in particular 1 to 5 times, the crude condensation product.
  • the aqueous alkaline hydrolysis is carried out until the diamide present as a by-product is virtually completely eliminated.
  • the diamide content of the crude product and its decrease in the treatment according to the invention can in a known manner, for. B. can be determined by working with ion exchangers.
  • n has the value of 2 or 3; the preferred meaning for n is 2.
  • the most important starting amine in practice of the type concerned here is aminoethylethanolamine.
  • the fatty acids related to the condensation have carbon numbers in the range from 6 to 22, the range from 8 to 18 carbon atoms being particularly important.
  • the carboxylic acids can be present as pure components or as mixtures. They can be of natural and / or synthetic origin.
  • the condensation product pretreated by the alkaline hydrolysis in the sense of the invention is then converted to the finished amphoteric surfactant in a manner known per se.
  • the pretreatment according to the invention proves to be valuable not only for the production of the so-called imidazolinium surfactants, but rather it can be used in many different ways.
  • amphoteric surfactants can have alkylated and optionally quaternized nitrogen in the second reaction stage.
  • the invention comprises the production of such amphoteric surfactants using a condensation precursor which has been treated according to the alkaline hydrolytic process of the invention described.
  • the percentages relate to% by weight.
  • the diamide content is determined as follows: The condensation product is sent as an alcoholic solution through a strongly acidic ion exchanger. The eluate is evaporated and the remaining residue is related to the weight. The amount of diamide can be calculated by determining the S.Z. and the total nitrogen.
  • the finished product is clear and fluid, but shows deposits after 2 days.
  • the end product is clear, but becomes cloudy after 3 days.
  • the reaction was carried out analogously to 3.1, but before adding the chlorohydroxypropanesulfonic acid (sodium salt), stirring was carried out at 80-90 ° C. for 1 hour after the addition of 4.8 g (0.06 mol) of 50% sodium hydroxide solution.
  • the product is still clear after more than 6 months.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Photovoltaic Devices (AREA)
  • Fats And Perfumes (AREA)

Abstract

1. A process for purifying the crude condensation product of aminoalkyl alkanolamines corresponding to the following general formula H2 N-(CH2 )2 -NH-(CH2 )n -OH in which n is the number 2 or 3, and C6 -C22 fatty acids and, if desired, for subsequently alkylating and, optionally, quaternizing the purified condensation product to form amphoteric surfactants having improved stability in storage, characterized in that the crude condensation product of fatty acids and aminoalkyl alkanolamines is subjected to alkaline hydrolysis at temperatures in the range from 70 to 100 degrees C.

Description

Ein wichtiges Verfahren zur Herstellung von Amphotensiden geht von Kondensationsprodukten N-monosubstituierter Alkylendiamine aus, die in einer weiteren Reaktion mit Alkylierungsmitteln, beispielsweise Natriumchloracetat, alkyliert werden. Produkte auf Basis von N-Aminoethylethanolamin und Fettsäuren spielen als hautfreundliche Tenside eine große Rolle.An important process for the production of amphoteric surfactants is based on condensation products of N-monosubstituted alkylenediamines, which are alkylated in a further reaction with alkylating agents, for example sodium chloroacetate. Products based on N-aminoethylethanolamine and fatty acids play a major role as skin-friendly surfactants.

Das Verfahren zur Herstellung solcher Verbindungen ist grundsätzlich aus den US-PS-2 528 378, 2 528 379 und 2 528 380 bekannt. Während man früher der Annahme war, daß bei dieser Reaktion Alkylierungs- bzw. Quaternisierungsprodukte des Imidazolins entstehen würden, ist heute erwiesen, daß es sich überwiegend um Alkylierungs- bzw. Quaternierungsprodukte von Aminoamiden handelt, die durch Hydrolyse der Imidazolin-Zwischenstufe im wäßrigen Milieu entstehen, siehe hierzu beispielsweise DE-AS-1 084 414.The process for the preparation of such compounds is known in principle from US Pat. Nos. 2,528,378, 2,528,379 and 2,528,380. While it was previously assumed that this reaction would result in alkylation or quaternization products of imidazoline, it has now been shown that they are predominantly alkylation or quaternization products of aminoamides which are formed by hydrolysis of the imidazoline intermediate in an aqueous medium , see for example DE-AS-1 084 414.

Grundsätzlich verfährt man bei der Herstellung dieser Tenside derart, daß ca. 1 Mol Fettsäure bzw. Fettsäuregemisch mit einem Mol eines Aminoalkylalkanolamins - insbesondere Aminoethylethanolamin - unter allmählicher Steigerung der Temperatur, zuletzt im Vakuum, kondensiert werden. Dieses Kondensationsprodukt wird dann mit wechselnden Mengen eines Alkylierungsmittels, beispielsweise Natriumchloracetat, üblicherweise in wäßrig alkalischer Lösung ins Amphotensid überführt. Einzelheiten zu diesen Verfahrensstufen finden sich in der zitierten Literatur, vergleiche hierzu weiterhin Dr. K. Lindner »Tenside-Textilhilfsmittel-Waschrohstoffe« Wissenschaftliche Verlags GmbH, Stuttgart 1964 Seiten 1041/1042 und die hier zitierte Originalliteratur sowie DE-OS-2 752 116, offengelegte europäische Patentanmeldung 001 006 und US-PS-2 773 068 und 3 408 361.The basic procedure for the preparation of these surfactants is that about 1 mole of fatty acid or fatty acid mixture is condensed with one mole of an aminoalkylalkanolamine - in particular aminoethylethanolamine - with a gradual increase in temperature, lastly in vacuo. This condensation product is then converted to the amphoteric surfactant with varying amounts of an alkylating agent, for example sodium chloroacetate, usually in an aqueous alkaline solution. Details of these process stages can be found in the literature cited, see also Dr. K. Lindner "Tenside-Textile Aid Detergent Raw Materials" Wissenschaftliche Verlags GmbH, Stuttgart 1964 pages 1041/1042 and the original literature cited here as well as DE-OS-2 752 116, European patent application 001 006 and US-PS-2 773 068 and 3 408 361.

Die Qualität der erhaltenen Ampotenside und insbesondere ihre Lagerstabilität wird in entscheidender Weise von der Reinheit des in der ersten Kondensationsstufe erhaltenen Imidazolinderivats bestimmt. Die Reaktion zwischen Fettsäuren und Aminoalkylalkanolaminen verläuft nicht nur in Richtung auf die Bildung des gewünschten Imidazolinderivates, mehrfache Nebenreaktionen komplizieren das Reaktionsgeschehen. Die Bedeutung dieses Aspekts ist erst in letzter Zeit wieder herausgestellt worden, siehe hierzu E. G. Lomax »New and improved balanced amphoterics«, Manufacturing Chemist and Aerosol News, Band 50 Nr. 8, August 1979, Seiten 39 und 41. Beschrieben wird hier beispielsweise, daß die unerwünschten Nebenreaktionen in der Stufe der Imidazolinbildung durch einen Überschuß an Aminoethylethanolamin zurückgedrängt werden können, wobei jedoch dieser Überschuß am Reaktionsende durch Destillation entfernt werden muß. Überschüssiges Aminoethylethanolamin kann seinerseits jedoch durch Zyklisierung zum Piperazin neue Schwierigkeiten bringen. Die Reinheit des in erster Reaktionsstufe gewonnenen Imidazolins hat entscheidenden Einfluß auf die Lagerstabilität der durch anschließende Alkylierung gewonnenen Amphotenside bzw. ihrer wäßrigen Lösungen. Auch nur geringe Verunreinigungen führen nach kürzerer oder längerer Lagerzeit zur Abscheidung einer festen Phase, sei es in Form von Trübungen oder Niederschlägen. Solche Produkte sind für die praktische Verwertung unbrauchbar oder zumindest von nur beschränktem Wert.The quality of the ampotensides obtained and in particular their storage stability is crucially determined by the purity of the imidazoline derivative obtained in the first condensation step. The reaction between fatty acids and aminoalkylalkanolamines not only proceeds in the direction of the formation of the desired imidazoline derivative, multiple side reactions complicate the course of the reaction. The importance of this aspect has only recently been emphasized again, see EG Lomax "New and improved balanced amphoterics", Manufacturing Chemist and Aerosol News, Volume 50 No. 8, August 1979, pages 39 and 41. For example, that the undesirable side reactions in the stage of imidazoline formation can be suppressed by an excess of aminoethylethanolamine, but this excess must be removed at the end of the reaction by distillation. Excess aminoethylethanolamine, in turn, can create new difficulties by cyclization to the piperazine. The purity of the imidazoline obtained in the first reaction stage has a decisive influence on the storage stability of the amphoteric surfactants or their aqueous solutions obtained by subsequent alkylation. Even a small amount of contamination leads to the separation of a solid phase after a shorter or longer storage period, be it in the form of cloudiness or precipitation. Such products are unusable for practical use or at least of limited value.

Die Erfindung geht von der Aufgabe aus, im Rahmen der Herstellung der hier geschilderten Klasse von Amphotensiden Verbesserungen zu schaffen, die insbesondere in einer erhöhten Lagerstabilität der Amphotenside gekennzeichnet sind.The invention is based on the object of creating improvements in the production of the class of amphoteric surfactants described here, which are characterized in particular by increased storage stability of the amphoteric surfactants.

Die Erfindung will dabei auf möglichst einfache Weise durch Einschaltung eines einfachen Reinigungsschrittes am primär erhaltenen Kondensat aus Aminoalkylalkanolamin und Fettsäure hier vorliegende, störende Nebenprodukte beseitigen. Die Erfindung will damit bisher übliche kostenaufwendige Umwege zur Gewinnung eines möglichst reinen Kondensationsproduktes dieser ersten Verfahrensstufe überflüssig machen.The invention aims to eliminate the troublesome by-products present here by switching on a simple cleaning step on the condensate of aminoalkylalkanolamine and fatty acid obtained in the first place. The aim of the invention is to make the previously expensive detours for obtaining the purest possible condensation product of this first process stage superfluous.

Die Lehre der Erfindung geht von der überraschenden Feststellung aus, daß das rohe Kondensationsprodukt aus Fettsäuren und Aminoalkylalkanolaminen durch eine einfache alkalische Hydrolyse zu einem raffinierten Produkt umgewandelt werden kann, das bei der anschließenden Alkylierung und gegebenenfalls Quaternierung verbesserte Amphotenside mit insbesondere erhöhter Lagerstabilität liefert.The teaching of the invention is based on the surprising finding that the crude condensation product of fatty acids and aminoalkylalkanolamines can be converted by simple alkaline hydrolysis to a refined product which, in the subsequent alkylation and optionally quaternization, provides improved amphoteric surfactants with, in particular, increased storage stability.

Gegenstand der Erfindung ist dementsprechend ein Verfahren zur Raffination des rohen Kondensationsproduktes aus Aminoalkylalkanolaminen der allgemeinen Formel

Figure imgb0001
in der n die Zahl 2 oder 3 bedeutet, und Fettsäuren mit 6 bis 22 C-Atomen und gewünschtenfalls zur nachfolgenden Alkylierung und gegebenenfalls Quaternierung des gereinigten Kondensationsproduktes zu Amphotensiden mit erhöhter Lagerstabilität, wobei dieses Verfahren dadurch gekennzeichnet ist, daß man das rohe Kondensationsprodukt aus Fettsäuren und Aminoalkylalkanolaminen bei 70 bis 100°C einer alkalischen Hydrolyse unterwirft.The invention accordingly relates to a process for refining the crude condensation product from aminoalkylalkanolamines of the general formula
Figure imgb0001
in which n is the number 2 or 3, and fatty acids having 6 to 22 carbon atoms and, if desired, for subsequent alkylation and, if appropriate, quaternization of the purified condensation product to amphoteric surfactants with increased storage stability, this process being characterized in that the crude condensation product is obtained from fatty acids and subjecting aminoalkylalkanolamines to alkaline hydrolysis at 70 to 100 ° C.

Im erfindungsgemäßen Verfahren wird vorzugsweise die in dieser alkalischen Hydrolyse eingesetzte Alkalimenge auf die im rohen Kondensat vorliegende Menge des Diamids der allgemeinen Formel

Figure imgb0002
abgestimmt. Dabei wird insbesondere die Alkalimenge in dieser Verfahrensstufe so bemessen, daß sie vorzugsweise in wenigstens etwa equimolarem Betrag zum Diamid im rohen Kondensationsprodukt vorliegt.In the process according to the invention, the amount of alkali used in this alkaline hydrolysis is preferably based on the amount of the diamide of the general amount present in the crude condensate formula
Figure imgb0002
Voted. In this process step, the amount of alkali in particular is such that it is preferably present in the crude condensation product in at least an approximately equimolar amount to the diamide.

Die Erfindung geht von der Feststellung aus, daß sich der Gehalt an störenden Nebenprodukten im fertigen Tensid drastisch senken läßt, wenn man das Fettsäure/Amin-Kondensationsprodukt vor einer weiteren Reaktion mit Alkylierungsmitteln einer alkalischen Vorbehandlung in wäßrigem Milieu unterzieht. Wie sich anhand von Versuchen zeigen ließ, wird insbesondere im Laufe der Reaktion gebildetes Diamid durch wäßrige Lauge an der tert. Amid-Gruppe quantitativ in das Monoamid der primären Amino-Gruppe und Fettsäure gespalten. Die Fettsäure bildet bei der erfindungsgemäßen Reinigungsbehandlung Seife, die im Reaktionsgemisch verbleiben kann.The invention is based on the finding that the content of disruptive by-products in the finished surfactant can be drastically reduced if the fatty acid / amine condensation product is subjected to an alkaline pretreatment in an aqueous medium before a further reaction with alkylating agents. As can be shown from experiments, diamide formed in particular in the course of the reaction by aqueous alkali on the tert. Amide group quantitatively split into the monoamide of the primary amino group and fatty acid. In the cleaning treatment according to the invention, the fatty acid forms soap which can remain in the reaction mixture.

Es ist tatsächlich außerordentlich erstaunlich, daß die bisher nur mit vergleichsweise kostspieligen Reinigungsschritten zu bewältigenden Schwierigkeiten bezüglich der Lagerstabilität der ir letzter Stufe erhaltenen Amphotenside durch die erfindungsgemäße Zwischenbehandlung beseitigt werden. Hier muß jedoch berücksichtigt werden, daß die Alkylierung und gegebenenfalls Quaternierung des in erster Stufe erhaltenen Reaktionsproduktes - mit beispielsweise Natriumchloracetat - im wäßrig alkalischen Milieu erfolgt, wobei Verfahrensbedingungen bezüglich Temperatur und Alkalität gewählt werden, die mit den Bedingungen des erfindungsgemäßen Zwischenschritts mindestens vergleichbar sind. Es war nicht zu erwarten, daß die erfindungsgemäß vorgesehene separate alkalische Hydrolyse des rohen Kondensationsproduktes aus der ersten Verfahrensstufe bessere Ergebnisse liefern könnte als eine entsprechende wäßrig-alkalische Behandlung im Zuge der Alkylierung bzw. Quaternierung des Kondensationsproduktes.It is indeed extremely surprising that the difficulties with respect to the storage stability of the amphoteric surfactants obtained in the last stage, which have hitherto been overcome only with comparatively expensive cleaning steps, are eliminated by the intermediate treatment according to the invention. However, it must be taken into account here that the alkylation and optionally quaternization of the reaction product obtained in the first stage - with, for example, sodium chloroacetate - takes place in an aqueous alkaline medium, process conditions with regard to temperature and alkalinity being selected which are at least comparable to the conditions of the intermediate step according to the invention. It was not to be expected that the separate alkaline hydrolysis of the crude condensation product from the first process stage provided according to the invention could provide better results than a corresponding aqueous alkaline treatment in the course of the alkylation or quaternization of the condensation product.

Durch die erfindungsgemäße alkalische Vorbehandlung werden jedoch Produkte erhalten, die auch nach Verdünnung länger als 6 Monate klar bleiben. Kostspielige Reinigungsschritte wie Rückgewinnung des Aminüberschusses oder Destillation des Imidazolins sind nicht mehr erforderlich. Die erfindungsgemäße alkalische hydrolytische Behandlung erfolgt vorzugsweise im Temperaturbereich von 80 bis 90°C. Als Alkalien eignen sich insbesondere Alkalihydroxide, vor allem Natriumhydroxid. Die Alkalimenge liegt vorzugsweise im Bereich des etwa 1- bis 3fachen des equimolaren Alkalibedarfs, bezogen auf das im Kondensationsrohprodukt vorliegende Diamid. Insbesondere wird mit Alkalimengen im Bereich von 1 bis 2 Equivalenten, bezogen auf Diamid, gearbeitet. Das Kondensationsrohprodukt wird zur erfindungsgemäßen alkalischen Hydrolyse zweckmäßigerweise in einer Wassermenge suspensiert, die dem 0,5- bis 10fachen, insbesondere dem 1- bis 5fachen des Kondensationsrohproduktes entspricht. Die wäßrige alkalische Hydrolyse wird bis zur praktisch vollständigen Beseitigung des als Nebenprodukt vorliegenden Diamids durchgeführt. Der Diamidgehalt des Rohprodukts und sein Absinken bei der erfindungsgemäßen Behandlung kann in bekannter Weise z. B. durch Arbeiten mittels Ionenaustauscher bestimmt werden.However, the alkaline pretreatment according to the invention gives products which remain clear even after dilution for longer than 6 months. Costly cleaning steps such as recovery of the excess amine or distillation of the imidazoline are no longer necessary. The alkaline hydrolytic treatment according to the invention is preferably carried out in the temperature range from 80 to 90 ° C. Alkali hydroxides, especially sodium hydroxide, are particularly suitable as alkalis. The amount of alkali is preferably in the range of about 1 to 3 times the equimolar amount of alkali, based on the diamide present in the crude condensation product. In particular, alkali amounts in the range of 1 to 2 equivalents, based on diamide, are used. For the alkaline hydrolysis according to the invention, the crude condensation product is expediently suspended in an amount of water which corresponds to 0.5 to 10 times, in particular 1 to 5 times, the crude condensation product. The aqueous alkaline hydrolysis is carried out until the diamide present as a by-product is virtually completely eliminated. The diamide content of the crude product and its decrease in the treatment according to the invention can in a known manner, for. B. can be determined by working with ion exchangers.

Als Aminoalkylalkanolamine der allgemeinen Formel

Figure imgb0003
werden solche Verbindungen eingesetzt, in denen n den Wert von 2 oder 3 aufweist; die bevorzugte Bedeutung für n ist 2. Das für die Praxis wichtigste Ausgangsamin der hier betroffenen Art ist Aminoethylethanolamin. Die zur Kondensation mitverwandten Fettsäuren weisen Kohlenstoffzahlen im Bereich von 6 bis 22 auf, wobei besondere Bedeutung der Bereich von 8 bis 18 C-Atomen hat. Die Carbonsäuren können als reine Komponenten oder auch als Mischungen vorliegen. Sie können dabei natürlichen und/oder synthetischen Ursprungs sein.As aminoalkylalkanolamines of the general formula
Figure imgb0003
such compounds are used in which n has the value of 2 or 3; the preferred meaning for n is 2. The most important starting amine in practice of the type concerned here is aminoethylethanolamine. The fatty acids related to the condensation have carbon numbers in the range from 6 to 22, the range from 8 to 18 carbon atoms being particularly important. The carboxylic acids can be present as pure components or as mixtures. They can be of natural and / or synthetic origin.

Das im Sinne der Erfindung durch die alkalische Hydrolyse vorbehandelte Kondensationsprodukt wird dann in an sich bekannter Weise zum fertigen Amphotensid umgewandelt. Auch hier gelten wieder die Angaben des zitierten umfangreichen Standes der Technik. Die erfindungsgemäße Vorbehandlung erweist sich dabei als wertvoll nicht nur für die Herstellung der sogenannten Imidazolinium-Tenside, sie ist vielmehr vielfältig anwendbar. Klare und lagerbeständige Produkte werden auch erhalten bei Umsetzung der alkalisch behandelten Amin-Kondensationsprodukte mit Alkylierungsmitteln von der Art der Chlorhydroxypropansulfonsäure, des Propansultons sowie bei der Alkylierung mit vinylogen Verbindungen wie Acrylsäure bzw. Acrylsäureester mit anschließender Verseifung und 2-Acrylamido-2-methylpropansulfonsäure bzw. den entsprechenden Alkalisalzen.The condensation product pretreated by the alkaline hydrolysis in the sense of the invention is then converted to the finished amphoteric surfactant in a manner known per se. Here too, the details of the cited extensive prior art apply. The pretreatment according to the invention proves to be valuable not only for the production of the so-called imidazolinium surfactants, but rather it can be used in many different ways. Clear and storage-stable products are also obtained when the alkali-treated amine condensation products are reacted with alkylating agents of the type of chlorohydroxypropane sulfonic acid, propane sultone and in the case of alkylation with vinylogenic compounds such as acrylic acid or acrylic acid ester with subsequent saponification and 2-acrylamido-2-methylpropanesulfonic acid or the corresponding alkali salts.

Die Amphotenside können je nach Struktur und Ausmaß der Umsetzung in zweiter Reaktionsstufe alkylierten und gegebenenfalls quaternierten Stickstoff aufweisen. Die Erfindung umfaßt in einer weiteren Ausführungsform die Herstellung solcher Amphotenside unter Verwendung eines Kondensationsvorproduktes, das nach dem geschilderten alkalisch hydrolytischen Verfahren der Erfindung behandelt worden ist.Depending on the structure and extent of the reaction, the amphoteric surfactants can have alkylated and optionally quaternized nitrogen in the second reaction stage. In a further embodiment, the invention comprises the production of such amphoteric surfactants using a condensation precursor which has been treated according to the alkaline hydrolytic process of the invention described.

In den folgenden Beispielen beziehen sich die Prozentangaben auf Gew.-%. Der Diamidgehalt wird wie folgt bestimmt: Das Kondensationsprodukt wird als alkoholische Lösung über einen stark sauren lonenaustauscher geschickt. Das Eluat wird eingedampft und der verbleibende Rückstand in Relation zur Einwaage gesetzt. Durch Bestimmung der S. Z. und des Gesamtstickstoffs läßt sich die Diamidmenge errechnen.In the following examples, the percentages relate to% by weight. The diamide content is determined as follows: The condensation product is sent as an alcoholic solution through a strongly acidic ion exchanger. The eluate is evaporated and the remaining residue is related to the weight. The amount of diamide can be calculated by determining the S.Z. and the total nitrogen.

Beispiel 1example 1 Kondensationsprodukte von Fettsäuren mit AminoethylethanolaminCondensation products of fatty acids with aminoethylethanolamine 1.1 Molverhältnis 1 : 11.1 molar ratio 1: 1

In einem Dreihalskolben, versehen mit Rührer, Stickstoffdurchfluß, Thermometer und Destillationsaufsatz wurden 208 g (1 Mol) Kokosfettsäure C8/18 mit 104 g (1 Mol) Aminoethylethanolamin vermischt und langsam auf 200°C erhitzt; Dauer ca. 6 Std. Nach Abdestillation von insgesamt 20 g aminhaltigem Wasser wurden ca. 290 g einer langsam erstarrenden, gelben Masse erhalten, die folgende Kennzahlen aufwies:

Figure imgb0004
In a three-necked flask equipped with a stirrer, nitrogen flow, thermometer and distillation attachment, 208 g (1 mol) of C8 / 18 coconut fatty acid were mixed with 104 g (1 mol) of aminoethylethanolamine and slowly heated to 200 ° C .; Duration approx. 6 hours. After distilling off a total of 20 g of water containing amine, about 290 g of a slowly solidifying, yellow mass were obtained, which had the following key figures:
Figure imgb0004

Diamid-Gehalt (ermittelt über lonenaustauscher) 16,1% (=0,04 Mol/100 g). Eine UV-spektrosk.Diamide content (determined via ion exchanger) 16.1% (= 0.04 mol / 100 g). A UV spectroscopic.

Untersuchung bei 230 mm ergab einen Imidazolingehalt von 8,0%.Examination at 230 mm showed an imidazoline content of 8.0%.

1.2 Molverhältnis 1 : 1,11.2 molar ratio 1: 1.1

Wie unter 1.1 beschrieben wurden 208 g (1 Mol) Kokosfettsäure mit 114,5 g (1,1 Mol) Aminoethylethanolamin kondensiert.As described under 1.1, 208 g (1 mol) of coconut fatty acid were condensed with 114.5 g (1.1 mol) of aminoethylethanolamine.

Erhalten wurden ca. 300 g einer langsam erstarrenden, gelben Masse mit folgenden Kennzahlen:

Figure imgb0005
Approx. 300 g of a slowly solidifying, yellow mass were obtained with the following key figures:
Figure imgb0005

1.3 Molverhältnis 1 : 1,51.3 molar ratio 1: 1.5

Wie unter 1.1 beschrieben, wurden 208 g (1 Mol) Kokosfettsäure mit 156 g (1,5 Mol) Aminoethylethanolamin unter langsamem Aufheizen so kondensiert, daß während der Reaktion der Gehalt an freiem Amin möglichst hoch blieb. Reaktionstemp. bis 180°C, zuletzt bei ca. 14 mbar.As described under 1.1, 208 g (1 mol) of coconut fatty acid were condensed with 156 g (1.5 mol) of aminoethylethanolamine with slow heating so that the free amine content remained as high as possible during the reaction. Reaction temp. up to 180 ° C, lastly at approx. 14 mbar.

Nach dem Abdestillieren des überschüssigen Amins verblieben ca. 270 g Rückstand mit folgenden Kennzahlen:

Figure imgb0006
After the excess amine had been distilled off, about 270 g of residue remained with the following key figures:
Figure imgb0006

Beispiel 2Example 2 Umsetzungen mit NatriumchloracetatReactions with sodium chloroacetate 2.1 Ohne alkalische Vorbehandlung2.1 Without alkaline pretreatment

  • 2.1.1. 90g (0,3 Mol, errechnet aus Ntitr) Produkt aus Versuch 1.1 wurden mit 148g Wasser dispergiert und bei 60°C mit 203 g (0,7 Mol) einer frisch bereiteten 40%igen Natriumchloracetat-Lösung versetzt. Beim Zugeben von 56 g (0,7 Mol) 50%iger Natronlauge stieg der pH-Wert auf 11,52 an. Man rührte 2 Std. bei dieser Temperatur und erhöhte dann für 1 Std. auf 80°C; der pH-Wert fiel langsam auf ca. 10. Das ca. 40%ige Produkt begann nach 2 Tagen bei R. T. einzutrüben.2.1.1. 90 g (0.3 mol, calculated from N titr ) of product from experiment 1.1 were dispersed with 148 g of water and 203 g (0.7 mol) of a freshly prepared 40% sodium chloroacetate solution were added at 60 ° C. When adding 56 g (0.7 mol) of 50% sodium hydroxide solution the pH rose to 11.52. The mixture was stirred at this temperature for 2 hours and then raised to 80 ° C. for 1 hour; the pH slowly dropped to approx. 10. The approx. 40% product began to cloud over after 2 days at RT.
  • 2.1.2. 80 g (0,32 Mol, errechnet aus Ntitr.) Produkt aus Versuch 1.2 wurden mit 134 g Wasser dispergiert und bei 60° C mit 214 g (0,74 Mol) einer frisch bereiteten 40%igen Lösung von Natriumchloracetat versetzt. Alsdann ließ man bei 60°C 58,8 g (0,74 Mol) 50%ige Natronlauge zulaufen, hielt die Mischung 2 Std. auf 60°C und erhöhte die Temperatur alsdann auf 80° C; der pH-Wert stellte sich bei Zugabe der Natronlauge auf 11,5 ein und sank nach 1 Std. Erhitzen bei 80° C lansam auf 10,1 ab. Erhalten wurde eine klare Lösung mit ca. 40% Feststoffgehalt, die jedoch bereits nach 2 Tagen bei R. T. einzutrüben begann.2.1.2. 80 g (0.32 mol, calculated from N titr. ) Product from experiment 1.2 were dispersed with 134 g of water and 214 g (0.74 mol) of a freshly prepared 40% solution of sodium chloroacetate were added at 60 ° C. 58.8 g (0.74 mol) of 50% sodium hydroxide solution were then run in at 60 ° C., the mixture was kept at 60 ° C. for 2 hours and the temperature was then increased to 80 ° C.; the pH was adjusted to 11.5 upon addition of the sodium hydroxide solution and slowly decreased to 10.1 after heating at 80 ° C. for 1 hour. A clear solution with about 40% solids content was obtained, which, however, began to cloud over after only 2 days at RT.
  • 2.1.3 90 g (0,3 Mol) Imidazolin aus Versuch 1.3 wurden mit 134 g Wasser dispergiert, 1 Std. bei 60°C gehalten und alsdann mit 203 g (0,7 Mol) einer frisch bereiteten 40% Natriumchloracetat-Lösung versetzt. Alsdann wurden 56 g (0,7 Mol) 50% Natronlauge zugesetzt. Der pH-Wert stieg auf 11,6 an. Es wurde 2 Std. bei dieser Temperatur und eine weitere Std. bei 80° C gerührt. Nach ca. 10 Wochen Aufbewahrung bei R. T. zeigten sich die ersten Trübungserscheinungen.2.1.3 90 g (0.3 mol) of imidazoline from experiment 1.3 were dispersed with 134 g of water, kept at 60 ° C. for 1 hour and then 203 g (0.7 mol) of a freshly prepared 40% sodium chloroacetate solution were added . Then 56 g (0.7 mol) of 50% sodium hydroxide solution were added. The pH rose to 11.6. The mixture was stirred at this temperature for 2 hours and at 80 ° C. for a further hour. After about 10 weeks of storage at R. T., the first signs of turbidity appeared.
2.2 Mit alkalischer Vorbehandlung2.2 With alkaline pretreatment

  • 2.2.1 a) 90 g (0,3 Mol, errechnet aus Ntitr.) Produkt aus Versuch 1.1, enthaltend 0,035 Mol Diamid, wurden in 148 g Wasser dispergiert, mit 1,2 g 50% NaOH (0,015 Mol) versetzt und 1 Std. bei 80 - 90° C gerührt Danach wurde verfahren wie unter 2.1.1. beschrieben. Das Produkt fällt klar an wie unter 2.1.1, trübt jedoch nach 6 Tagen auch ein, da nicht alles Diamid verseift wurde.
    • b) Der Versuch wurde wiederholt unter Zusatz von 4,8 g 50% NaOH (0,06 Mol). Das Diamid wurde, wie auch die Analyse zeigte, quantitativ zum Monoacylprodukt verseift, das Produkt ist auch nach > 6 Mon. noch klar.
    2.2.1 a) 90 g (0.3 mol, calculated from N titr. ) Product from experiment 1.1, containing 0.035 mol diamide, were dispersed in 148 g water, 1.2 g 50% NaOH (0.015 mol) were added and Stirred at 80-90 ° C. for 1 hour. The procedure was as in 2.1.1. described. The product is clear as in 2.1.1, but also clouded after 6 days, since not all diamide has been saponified.
    • b) The experiment was repeated with the addition of 4.8 g of 50% NaOH (0.06 mol). As the analysis also showed, the diamide was saponified quantitatively to give the monoacyl product; the product is still clear even after> 6 months.
  • 2.2.2 80 g (0,32 Mol) Produkt aus Versuch 1.2 wurden in 60 g Wasser dispergiert, mit 4,8 g (0,06 Mol) 50% Natronlauge versetzt und 1 Std. bei 80°C gerührt. Nach weiterer Umsetzung, wie unter 2.1.2 beschrieben, wurde ein Tensid erhalten, das auch nach > 6 Mon. noch klar ist.2.2.2 80 g (0.32 mol) of product from experiment 1.2 were dispersed in 60 g of water, mixed with 4.8 g (0.06 mol) of 50% sodium hydroxide solution and stirred at 80 ° C. for 1 hour. After further implementation, as described under 2.1.2, a surfactant was obtained which is still clear even after> 6 months.

Aus den Versuchen 2.1.1 -2.1.3 sowie 2.2.1 und 2.2.2 ist ersichtlich:

  • Auch die Verwendung eines sehr reinen Imidazolins als Vorstufe (2.1.3) führt nicht zu der Qualitätsverbesserung, wie sie selbst bei diamidreichen Rohstoffen (1.1 u. 1.2) nach alkalischer Vorbehandlung erreicht wird. Zweckmäßigerweise wird eine Natronlaugemenge eingesetzt, die äquivalent, am besten jedoch etwa doppelt so hoch ist, wie aufgrund des Diamid-Gehalts erforderlich ist.
From experiments 2.1.1-2.1.3 and 2.2.1 and 2.2.2 it can be seen:
  • The use of a very pure imidazoline as a preliminary stage (2.1.3) does not lead to the quality improvement that is achieved even with diamide-rich raw materials (1.1 and 1.2) after alkaline pretreatment. An amount of sodium hydroxide solution is expediently used, which is equivalent, but ideally about twice as high as is necessary due to the diamide content.

Beispiel 3Example 3 Umsetzungen mit 2-Acrylamido-2-methylpropansulfonsäure (AMPS) bzw. Na-SalzReactions with 2-acrylamido-2-methylpropanesulfonic acid (AMPS) or Na salt 3.1 Ohne alkalische Vorbehandlung3.1 Without alkaline pretreatment

75,0 g (0,3 Mol, errechnet aus Ntitr.) Produkt aus Versuch 1.2 wurden in 200 g Wasser suspendiert, mit 80,6 g (0,39 Mol) AMPS versetzt und dann mit 31,2 g (0,39 Mol) 50% Natronlauge. Es wurde 4 Std. bei 80° C gerührt.75.0 g (0.3 mol, calculated from nitrite ) . Product from experiment 1.2 were suspended in 200 g of water, 80.6 g (0.39 mol) of AMPS were added, and then 31.2 g (0.1 39 mol) 50% sodium hydroxide solution. The mixture was stirred at 80 ° C for 4 hours.

Das fertige Produkt ist klar und dünnflüssig, zeigt jedoch nach 2 Tagen bereits Abscheidungen.The finished product is clear and fluid, but shows deposits after 2 days.

3.2 Mit alkalischer Vorbehandlung3.2 With alkaline pretreatment

75,0 g (0,3 Mol) Produkt aus Versuch 1.2 wurden in 200 g Wasser suspendiert und 1 Std. mit 4,8 g (0,06 Mol) 50% Natronlauge bei 80 - 90° C gerührt. Weitere Umsetzung wie unter 3.1. Das Produkt ist auch nach > 6 Mon. noch völlig klar.75.0 g (0.3 mol) of product from experiment 1.2 were suspended in 200 g of water and stirred for 1 hour with 4.8 g (0.06 mol) of 50% sodium hydroxide solution at 80-90 ° C. Further implementation as under 3.1. The product is still completely clear after> 6 months.

Beispiel 4Example 4 Umsetzungen mit Chlorhydroxypropansulfonsäure bzw. Na-SalzReactions with chlorhydroxypropanesulfonic acid or Na salt 4.1 Ohne alkalische Vorbehandlung4.1 Without alkaline pretreatment

75 g (0,3 Mol) Produkt aus Versuch 1.2 wurden in 200 ml Wasser dispergiert, mit 63,6 g (0,3 Mol) Chlorhydroxypropansulfonsäure (Na-Salz) versetzt und in 30 Min. bei 80°C mit 24,0 g (0,3 Mol) 50% Natronlauge. 4 Std. Nachreaktion bei 50° C.75 g (0.3 mol) of product from experiment 1.2 were dispersed in 200 ml of water, 63.6 g (0.3 mol) of chlorohydroxypropanesulfonic acid (Na salt) were added and 24.0 at 80 ° C. in 30 minutes g (0.3 mol) 50% sodium hydroxide solution. 4 hours after-reaction at 50 ° C.

Das Endprodukt ist klar, trübt jedoch nach 3 Tagen ein.The end product is clear, but becomes cloudy after 3 days.

4.2 Mit alkalischer Vorbehandlung4.2 With alkaline pretreatment

Die Umsetzung erfolgte analog 3.1, jedoch wurde vor Zugabe der Chlorhydroxypropansulfonsäure (Na-Salz) 1 Std. bei 80-90°C nach Zugabe von 4,8 g (0,06 Mol) 50% Natronlauge gerührt.The reaction was carried out analogously to 3.1, but before adding the chlorohydroxypropanesulfonic acid (sodium salt), stirring was carried out at 80-90 ° C. for 1 hour after the addition of 4.8 g (0.06 mol) of 50% sodium hydroxide solution.

Das Produkt ist nach über 6 Mon. noch klar.The product is still clear after more than 6 months.

Beispiel 5Example 5 Umsetzungen mit AcrylsäureReactions with acrylic acid 5.1 Ohne alkalische Vorbehandlung5.1 Without alkaline pretreatment

75,0 g (0,3 Mol) Produkt aus Versuch 1.1 wurden mit 21,6 g (0,3 Mol) Acrylsäure vermischt und 4 Std. bei 80° C gerührt und dann mit 145 g Wasser verdünnt. Das Produkt wird nach 2 Wochen trüb.75.0 g (0.3 mol) of product from experiment 1.1 were mixed with 21.6 g (0.3 mol) of acrylic acid and stirred for 4 hours at 80 ° C. and then diluted with 145 g of water. The product becomes cloudy after 2 weeks.

5.2 Mit alkalischer Vorbehandlung5.2 With alkaline pretreatment

75,0 g (0,3 Mol) Produkt aus Versuch 1.1 wurden mit 4,8 g (0,06 Mol) 50% Natronlauge 1 Std. bei 80° C gerührt und dann wie unter 4.1 weiterbehandelt.75.0 g (0.3 mol) of product from experiment 1.1 were stirred with 4.8 g (0.06 mol) of 50% sodium hydroxide solution at 80 ° C. for 1 hour and then treated as in 4.1.

Das Produkt bleibt >6 Mon. klar.The product remains clear for> 6 months.

Claims (4)

1. A process for purifying the crude condensation product of aminoalkyl alkanolamines corresponding to the following general formula
Figure imgb0008
in which n is the number 2 or 3, and C6―C22 fatty acids and, if desired, for subsequently alkylating and, optionally, quaternizing the purified condensation product to form amphoteric surfactants having improved stability in storage, characterized in that the crude condensation product of fatty acids and aminoalkyl alkanolamines is subjected to alkaline hydrolysis at temperatures in the range from 70 to 100" C.
2. A process as claimed in Claim 1, characterized in that the quantity of alkali used in the alkaline hydrolysis step is coordinated with the quantity of diamide present in the crude condensation product, the alkali preferably being used at least approximately in an equimolar quantity and, more particularly, in no more than 3 times the molar quantity.
3. A process as claimed in Claims 1 and 2, characterized in that the alkaline hydrolysis step is carried out at temperatures in the range from 80 to 90° C.
4. A process as claimed in Claims 1 to 4, characterized in that pure fatty acids or fatty acid mixtures containing the number of carbon atoms indicated above and, more particularly, from 8 to 18 carbon atoms, are used.
EP81103328A 1980-05-13 1981-05-02 Process for refining a raw condensation product from aminoalkylalkanol amines and fatty acids, and as soon as required for the subsequent recovery of amphotensides with higher stability Expired EP0040346B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT81103328T ATE5815T1 (en) 1980-05-13 1981-05-02 PROCESS FOR REFINING THE RAW CONDENSATION PRODUCT OF AMINOALKYLAKANOLAMINES AND FATTY ACIDS AND, IF DESIRED, FOR THE SUBSEQUENT RECOVERY OF AMPHOTENSIDES WITH INCREASED STORAGE STABILITY.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3018201 1980-05-13
DE19803018201 DE3018201A1 (en) 1980-05-13 1980-05-13 METHOD FOR REFINING THE RAW CONDENSATION PRODUCT FROM AMINOALKYLALKANOLAMINES AND FATTY ACIDS, AND IF NECESSARY FOR THE FOLLOWING DETERMINATION OF AMPHOTENSIDE WITH INCREASED STORAGE STABILITY

Publications (2)

Publication Number Publication Date
EP0040346A1 EP0040346A1 (en) 1981-11-25
EP0040346B1 true EP0040346B1 (en) 1984-01-11

Family

ID=6102253

Family Applications (1)

Application Number Title Priority Date Filing Date
EP81103328A Expired EP0040346B1 (en) 1980-05-13 1981-05-02 Process for refining a raw condensation product from aminoalkylalkanol amines and fatty acids, and as soon as required for the subsequent recovery of amphotensides with higher stability

Country Status (9)

Country Link
EP (1) EP0040346B1 (en)
JP (1) JPS5716846A (en)
AT (1) ATE5815T1 (en)
AU (1) AU541532B2 (en)
BR (1) BR8102948A (en)
CA (1) CA1214778A (en)
DE (2) DE3018201A1 (en)
ES (1) ES502137A0 (en)
MX (1) MX156685A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3444864A1 (en) * 1984-12-08 1986-06-12 Henkel KGaA, 4000 Düsseldorf METHOD FOR GREATING LEATHER AND FURS
DE3641871A1 (en) * 1986-12-08 1988-06-09 Henkel Kgaa METHOD FOR THE PRODUCTION OF LIQUID AMPHOTENSIDE
DE4038983A1 (en) * 1990-12-06 1992-06-11 Henkel Kgaa METHOD FOR THE PRODUCTION OF FLUID-LIQUID IMIDAZOLINIUM TENSIDES BY QUATERNATION OF 1-HYDROXYETHYL-2-ALKYLIMIDAZOLINES
DE4240154A1 (en) * 1992-11-30 1994-06-01 Henkel Kgaa Process for the production of low viscosity, storage stable amphoteric surfactants
CA2132289A1 (en) * 1993-10-12 1995-04-13 Bharat Desai Higher purity imidazoline based amphoacetate surfactants and processes for the preparation thereof
DE19715383A1 (en) * 1997-04-14 1998-10-15 Clariant Gmbh Amphoglycinates as anti-corrosion agents for ferrous and non-ferrous metals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5938221B2 (en) * 1976-01-20 1984-09-14 ライオン株式会社 Method for producing quaternary ammonium salt
JPS5951532B2 (en) * 1976-09-03 1984-12-14 川研フアインケミカル株式会社 Novel amine amide compound, method for producing the same, and surfactant containing the amine amide compound
JPS5368721A (en) * 1976-12-01 1978-06-19 Lion Corp Disubstd. aliphatic carboxylic acid amide amines, and detergents and cosmeticcompositions containing the same
DK153682C (en) * 1977-08-18 1988-12-27 Albright & Wilson ORGANIC NITROGEN CONNECTIONS AND PROCEDURE FOR THEIR PREPARATION AND USE OF THE COMPOUNDS IN SHAMPOO

Also Published As

Publication number Publication date
ES8203830A1 (en) 1982-04-01
JPH0249299B2 (en) 1990-10-29
DE3018201A1 (en) 1981-11-19
MX156685A (en) 1988-09-26
JPS5716846A (en) 1982-01-28
DE3161875D1 (en) 1984-02-16
ES502137A0 (en) 1982-04-01
BR8102948A (en) 1982-02-02
AU7051181A (en) 1981-11-19
AU541532B2 (en) 1985-01-10
EP0040346A1 (en) 1981-11-25
CA1214778A (en) 1986-12-02
ATE5815T1 (en) 1984-01-15

Similar Documents

Publication Publication Date Title
DE3826654C1 (en)
DE3048283A1 (en) METHOD FOR PRODUCING HYDROXYALKYLAMINOSULPHONIC ACIDS
EP0040346B1 (en) Process for refining a raw condensation product from aminoalkylalkanol amines and fatty acids, and as soon as required for the subsequent recovery of amphotensides with higher stability
DE2505902C2 (en) Process for the preparation of 2,5-dimethyl-3- (2H) -furanone
EP0671382B1 (en) Fluorinated carboxybetaines and alkylsulfobetaines as well as the mixtures thereof with saturated fluoroalkylamines
EP0670830B1 (en) Process for preparing fluid, storage-stable ampholytic surface-active agents
DE69006789T2 (en) Process for the preparation of sulfoalkyl-substituted hydroxylamines.
EP0452349B1 (en) Process for producing amphoteric surface-active imidazoline derivatives
EP0005446B1 (en) Amino-ether amphoteric surface-active compounds and process for their preparation
EP0275421B1 (en) Process for the preparation of highly viscous amphotensides
DE69420274T2 (en) PRODUCTION OF AMMONIUM HYDROXYALKYL / ALKANOYLALKYL SULFONATES
DE707426C (en) Production of unsaturated aldehydes
DE2065698C3 (en) Process for the preparation of 2-isopropyl-6-methyl-4 (3H) -pyrimidone
DE2725780C2 (en)
DE3015374A1 (en) METHOD FOR THE PRODUCTION OF UREA
DE1010065B (en) Process for the preparation of complex-forming 2-oxycyclohexyl-substituted aminoacetic acids, their salts or metal complex salts
DE19712012A1 (en) Ethoxy:benzyl-di:ethylene tri:amine penta:acetic acid preparation
DE3641603C2 (en) Process for the preparation of purified phosphoric acid ester salts
DE2236120C3 (en) Process for the preparation of aminocarboxylic acid alkali metal salts from amino alcohols
DE2944257A1 (en) METHOD FOR PRODUCING N-CYAN-N'-METHYL-N '' - (2-MERCAPTOAETHYL) GUANIDINE
DE1024972B (en) Process for the preparation of 2-hydrocarbon-substituted imidazoline propionic acids and their salts
DE744756C (en) Process for the preparation of 6-isoamylamino-2-methylheptane
DE69112077T2 (en) METHOD FOR PRODUCING ETHANOLAMIDE ALKOXYLATES.
DE1493650A1 (en) Process for the production of surface-active compounds
DE762219C (en) Process for the preparation of water-soluble alkylated cycloaliphatic amines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LU NL SE

17P Request for examination filed

Effective date: 19811029

ITF It: translation for a ep patent filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI NL SE

REF Corresponds to:

Ref document number: 5815

Country of ref document: AT

Date of ref document: 19840115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3161875

Country of ref document: DE

Date of ref document: 19840216

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
ITTA It: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19920421

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19920504

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19920521

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Effective date: 19930502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19930503

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19930531

Ref country code: CH

Effective date: 19930531

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19940531

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19940711

Year of fee payment: 14

EUG Se: european patent has lapsed

Ref document number: 81103328.1

Effective date: 19931210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Effective date: 19950531

BERE Be: lapsed

Owner name: HENKEL K.G.A.A.

Effective date: 19950531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19951201

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 19951201

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19960419

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19960423

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19960510

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19970502

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19970502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980203

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST